Sudden-onset rapid breathing commonly occurs in previously calm, invasively-ventilated patients. In most cases it can be resolved easily by traditional management techniques, but other cases can be very challenging. We enrolled 40 patients who failed traditional interventions and performed short-term high-pressure support ventilation (HPSV). Thirty-three (83%) patients were responsive to HPSV. In the responders, ten minute HPSV reduced mean airway pressure (P=0.030), minute ventilation (P <0.001), respiratory rate (P <0.001) and heart rate (P <0.001) compared to before HPSV therapy. It also stabilised tidal volume (P <0.001) and improved oxygenation (P=0.007). After 58 minutes, HPSV relieved tachypnoea. However, compared with the responders, the non-responders (7/40, 17%) were younger (77.0 versus 59.7 years, P=0.002), and had higher Glasgow Coma Scale score (9.0 versus 14.0, P <0.001), pressure support (P=0.029), peak pressure (P=0.048) and heart rate (P=0.004) before sudden-onset rapid breathing. The non-responders also had higher peak pressure (P=0.046), minute ventilation (P=0.024), respiratory rate (P=0.027) and heart rate (P <0.001) when the rapid breathing happened. At or before sudden-onset rapid breathing, peak pressure, minute ventilation and heart rate had a high accuracy to predict the non-responsive patients (each with area under the curve of ≥0.7). The age and Glasgow Coma Scale also had high predicted ability (both with areas under the curve of ≥0.8). In conclusion, short-term HPSV relieved persistent sudden-onset rapid breathing. However, it was not effective in the relatively young and conscious patients with relatively high support pressure, peak pressure, minute ventilation and heart rate.
Invasive ventilation is increasingly used as a lifesaving treatment for patients with respiratory failure as it decreases the work of breathing, improves oxygenation and ventilation, and allows time for other interventions to treat the cause of respiratory failure 1 , although patient-ventilator asynchrony occurs in nearly all invasively-ventilated patients 2 . High rates of asynchrony, defined as asynchrony for more than 10% of respiratory efforts, have been observed in 24% of patients 3, 4 . Sudden-onset rapid breathing is an indication of patient-ventilator asynchrony and commonly occurs in previously calm patients. This asynchrony may increase the heart rate, respiratory rate (RR), blood pressure and decrease oxygen levels. Solving this problem is a formidable challenge for critical care practitioners. The causes of sudden-onset rapid breathing can be classified as patient or ventilator-related. Practitioners may attempt to identify the possible causes by suctioning the airway, checking the tube position, performing a physical examination and initiating manual ventilation. If these general management techniques are not effective, the patient is usually sedated. However, this may decrease muscle function and increase the duration of mechanical ventilation and an intensive care unit (ICU) stay 5 .
In invasively-ventilated patients, short-term highpressure support ventilation (HPSV) may be an effective intervention for sudden-onset rapid breathing in which general management techniques are unsuccessful. Therefore we designed a before and after study to evaluate the effectiveness of short-term HPSV in these patients.
METHODS
The study was performed at a respiratory ICU of a teaching hospital from November 2010 to April 2011. It was approved by our institutional review board and informed consent was obtained from patients' next of kin. The inclusion criteria were age >18 years, no sedation, no analgesia, calm breathing before suddenonset rapid breathing (12 ≤ RR ≤20 breaths/minute) and positive end-expiratory pressure ≤6 cmH 2 O. The exclusion criteria were hypoxemia (P a O 2 ≤70 mmHg), recent surgery (≤20 days), acute respiratory distress syndrome (defined by the American-European Consensus Conference 6 ), pneumothorax, pneumonectomy and pneumatocele.
General management methods in sudden-onset rapid breathing patients
Sudden-onset rapid breathing was defined as a sudden increase in RR to more than 28 breaths/ minute in a previously calm patient and not preceded by suction, adjustment of ventilatory parameters or a change in posture. When sudden-onset rapid breathing occurred, we attempted to diagnose the problem and manage it according to general methods ( Figure 1 ). Routine interventions were usually completed within 20 minutes. If these measures failed, which was defined as the RR >28 breaths/minutes, we enrolled the patient in the study, recorded the data and performed HPSV.
HPSV procedure
We standardised the mechanical ventilation settings in all patients: synchronised intermittent mandatory ventilation and pressure support ventilation mode; pressure support; RR ten breaths/ minute; inspiratory time 1.1 seconds; and positive end-expiratory pressure and FiO 2 unchanged (NPB 840, Puritan-Bennett/Covidien, Carlsbad, CA, USA). The HPSV procedure is shown in Figure 2 . The pressure support was adjusted to 30 cmH 2 O for two minutes. If the patient's RR still exceeded 16 breaths/ minute, we characterised the protocol as ineffective (non-responsive). In the non-responders, we adjusted the parameters to previous settings and sedated the patients. If the patient's RR decreased to less than16 breaths/minute, we defined the procedure as effective (responsive). After the pressure was maintained at 30 cmH 2 O for two minutes in the responders, it was lowered in a stepwise fashion by 2 cmH 2 O each 30 seconds. If the RR exceeded 16 breaths/minute, pressure lowering was stopped. In these patients, we increased the pressure back to the previous step to maintain the RR below 16 breaths/minute (we defined this pressure as the lowest pressure). The lowest pressure was maintained for ten minutes, then the parameters were adjusted back to the settings used prior to HPSV and sustained for ten minutes (i.e. HPSV was paused). If the patient continued to exhibit tachypnoea, HPSV was performed again. If the patient's condition returned to its pre-suddenonset rapid breathing state, HPSV was stopped and the parameters kept at the settings used prior to HPSV.
The RR, heart rate, blood pressure and ventilator parameters were recorded prior to HPSV, during the initial ten-minute HPSV protocol and during the first pause in HPSV. The arterial blood gas was drawn during the initial ten-minute HPSV in patients for whom the therapy was effective. Three consecutive values of peak pressure, mean airway pressure, minute ventilation and RR were recorded and calculated as the average value. The causes of sudden onset rapid breath: 
Statistical analysis
The data were reported as mean ± standard deviation (SD) and analysed using statistical software (SPSS 17.0, SPSS, Chicago, IL, USA). The pairedsamples t-test was used to compare data obtained before HPSV to that collected during the initial tenminute HPSV in the effective patients, and before data to that collected during the initial two-minute HPSV in ineffective patients. The independent samples t-test was used to analyse responders versus non-responders when appropriate. A P value <0.05 was considered significant. A receiver-operating characteristic curve was constructed to evaluate the accuracy of the predictors (in which conditions the HPSV were non-responsive). The optimal cut-off value was chose by the maximum Youden index 7 . 
RESULTS
We consecutively enrolled 40 patients in the study. The characteristics of patients before sudden-onset rapid breathing are summarised in Table 1 In the responders, HPSV decreased the mean airway pressure (12.1±2.8 versus 11.3±1.7 cmH 2 O, P=0.030), coefficient of variation of V T (18.9±11.4 versus 4.9±4.3%, P <0.001), minute ventilation (14.0±2.6 versus 11.0±2.0 l, P <0.001), RR (32.7±3.9 versus 12.2±1.8 breaths/minute, P <0.001) and heart rate (105±17 versus 97±19 beats/minute, P <0.001) and increased the P a O 2 /FiO 2 (222.2±61.7 versus 248.0±78.7, P=0.007) after the initial tenminute treatment compared to before HPSV ( Table  3 ). However, during the first pause in HPSV, the responders' conditions returned to tachypnoea (one responder returned to a calm condition) ( Table 4 and Figure 3 ). In the non-responders, HPSV increased the peak pressure (25.9±4.7 versus 35.3±2.0 cmH 2 O, P=0.004), mean airway pressure (12.6±4.8 versus 18.2±2.6 cmH 2 O, P=0.016) and minute ventilation (16.7±3.2 versus 20.6±5.6 l, P=0.043) compared to before HPSV (Table 5) , although there were no significant differences in the coefficient of variation of V T , heart rate and blood pressure. Table 6 shows the predictive variables for nonresponsiveness and the optimal cut-off value for each variable. The most accurate predictors were the Glasgow Coma Scale score and heart rate (at sudden-onset rapid breathing), both had areas under the curve of ≥0.9. The age, heart rate before suddenonset rapid breathing and peak pressure at suddenonset rapid breath also had high accuracy to predict the non-responsiveness, all had areas under the curve of ≥0.8. Other variables had relatively lower accuracy to predict non-responsiveness. 
DISCUSSION
Sudden-onset rapid breathing can result from auto-trigger, double-trigger, late cycling, premature cycling, poor oxygenation, inadequate cuff pressure, malposition of the tube, a leak in the circuit, a large amount of secretions in the airway, bronchospasm and pneumothorax, among other causes 8, 9 . General management methods are designed to diagnose and correct the cause. In this study, we attempted to resolve rapid breathing with standard management techniques (Figure 1 ). We manually ventilated the patients with a self-inflating bag and tested the ventilators on a test lung. The ventilator worked normally and the patients still exhibited tachypnoea, thus excluding ventilator malfunctions. Improper ventilator parameters related to trigger, cycle and flow may be responsible, although the patients in our study were stable before sudden-onset rapid breathing and maintained a calm state after we adjusted the ventilator parameters back to the settings used prior to HPSV, after a mean of 58 minutes of treatment with HPSV ( Figure 3 ). This indicates that the ventilator parameters were not the cause of suddenonset rapid breathing. Because tachypnoea was not HPSV=high-pressure support ventilation, V T =tidal volume, l=litres, RR=respiratory rate. *P <0.05 for before HPSV versus after two-minute HPSV. †P <0.01 for before HPSV versus after two-minute HPSV.
relieved by manual ventilation in these subjects, its cause may be patient-related. In accordance with standard management methods, we checked the tube, monitored the cuff pressure, suctioned the airway, performed a physical examination and used bedside bronchoscopy (Figure 1) ; none of these, however, resolved the patients' rapid breathing. Before HPSV, arterial blood gas values and tidal volume and minute ventilation measurements (Table 1) indicated that ventilation and oxygenation were adequate. After we excluded all possible causes, we attempted to use HPSV to solve the problem. After an initial ten minutes of HPSV, we adjusted the parameters to their pre-HPSV settings, and the patients' RR once again became rapid ( Table 4 ), suggesting that HPSV is an effective intervention for patients with persistent sudden-onset rapid breathing. Tobin advises that sedative agents can be administered if medical and mechanical problems have been excluded and the patient continues to show distress 9 . When the right drug(s) in the right dose are given to the right patient at the right time for the right reasons, sedation decreases anxiety and improves comfort and patient-ventilator synchrony 10 . However, sedation weakens the function of diaphragmatic muscle, an effect common in patients who receive passive ventilation for more than 24 hours, which increases both the duration of mechanical ventilation and the length of an ICU stay [11] [12] [13] . In this study, rapid breathing was relieved without sedation in 83% of patients. In these patients, pressure and flow waveforms indicated that patient-ventilator synchrony was improved according to the methods described by Georgopoulos 14 . HPSV also significantly increased oxygenation, decreased RR and minute ventilation and stabilised the tidal volume (Table 3) .
In this study, the V T was very high during HPSV (Table 3) ; this situation may result in volutrauma. Maruscak et al reported that continuous high tidalvolume ventilation (V T 30 ml/kg) did not decrease P a O 2 /FiO 2 and surfactant proteins A and B of the lung when maintained for one hour 15 . Copland et al reported that the injury score after continuous high tidal-volume ventilation (V T 25 ml/kg) for 30 minutes was similar in the control group (V T 5 ml/kg) 16 . In our study, we performed HPSV for ten minutes, shifted the parameters to those used prior HPSV for ten minutes and cycled the intervention until the patient's RR was reduced to a calm condition. The duration of HPSV ranged from 20 to 170 minutes (Figure 3) , thus, we avoided volutrauma.
Petersen et al reported that HPSV did not result in barotrauma when the peak airway pressure was less than 60 cmH 2 O. However, a high level of positive end-expiratory pressure increased the incidence of barotrauma 17 . Boussarsar et al reported that a high incidence of pneumothorax was strongly correlated with a plateau pressure above 35 cmH 2 O 18 . Anzueto et al reported that patients with or without barotrauma had similar peak pressures (>50 cmH 2 O), plateau pressure (>35 cmH 2 O) and tidal volumes (>12 ml/ kg) 19 . Similar findings were reported by Weg and Stewart 20, 21 . In our study, the support and peak pressures were 26.8 and 32.4 cmH 2 O, respectively, in responsive patients (Table 3 ). During each 20-minute cycle, we used the HPSV for ten minutes and common pressure support (pre-HPSV settings) for ten minutes. In addition, in the non-responsive patients, we kept the pressure at 30 cmH 2 O for two minutes and then shifted the parameters back to the pre-HPSV values. These interventions may avoid barotrauma.
Tables 1 and 2 compare the characteristics of the responders and non-responders. The non-responders were younger and had higher scores on the Glasgow Coma Scale. The heart rate was also higher in the nonresponders during the calm condition and increased more sharply during sudden-onset rapid breathing. Both before and during sudden-onset rapid breathing, the peak pressure was higher in the non-responders. It may indicate that the HPSV was ineffective in these patients.
Our study has several limitations. Although we attempted to identify the causes of sudden onset rapid breathing (Figure 1) , other potential causes such as embolism may contribute to rapid breathing. Maybe the HPSV was ineffective in these patients. In addition, we enrolled 40 patients in this study and HPSV was effective in 83%. The small sample size and lack of a control group may diminish the significance of the results. Although we observed that HPSV relieved persistent sudden-onset rapid breathing, the mechanism of action is unclear. The Hering-Breuer inflation reflex may explain the decrease in respiratory rate during the HPSV 22 , although it could not explain why the respiratory rate returned to the calm condition after several cycles of HPSV. Other mechanisms should be further explored. Another limitation is that we did not define how many times the cycle was continued in HPSV. Based on our experience, if the total time of the cycles is beyond 180 minutes, other interventions should be considered.
CONCLUSIONS
HPSV relieved persistent sudden-onset rapid breathing, increased oxygenation, improved vital signs and stabilised tidal volume may be effective for resolving sudden-onset rapid breathing in patients for whom general interventions without sedation are ineffective. However, it was not effective in the relatively young and conscious patients with relatively high support pressure, peak pressure, minute ventilation and heart rate.
